One biologic, adalimumab, is currently approved to treat hidradenitis suppurativa. Adalimumab works by targeting a specific inflammation pathway involved in the condition. Hidradenitis suppurativa (HS ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback